Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chymotrypsin is a serine protease enzyme primarily involved in the digestion of proteins in the small intestine. It catalyzes the hydrolysis of peptide bonds, specifically those adjacent to aromatic amino acids such as phenylalanine, tryptophan, and tyrosine. It is synthesized in the pancreas as an inactive precursor (chymotrypsinogen) and activated in the digestive tract.
Covalent hydrolysis of peptide bonds adjacent to aromatic amino acids (Phe, Trp, Tyr) via acyl-enzyme intermediate formation.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chymotrypsin.